JSW
MD icon

Journey Strategic Wealth’s Pediatrix Medical MD Stock Holding History

Journey Strategic Wealth’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,848
Closed -$149K – 409
2024
Q1 		$149K Buy
+14,848
New +$138K 0.01% 300

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Journey Strategic Wealth's MD Position: Q2 2024 in Review

Journey Strategic Wealth sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 14,848 shares — an estimated $149K sold.

Journey Strategic Wealth first reported a position in MD in Q1 2024 and held it in 1 quarter. The position peaked at $149K in Q1 2024. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.

  • Journey Strategic Wealth reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
  • Journey Strategic Wealth sold 14,848 Pediatrix Medical shares in Q2 2024, an estimated $149K.
  • Journey Strategic Wealth first reported a position in Pediatrix Medical in Q1 2024 and held it in 1 quarter.
  • Journey Strategic Wealth's Pediatrix Medical position peaked at $149K in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.

Based on Journey Strategic Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.